Hu Ya-Guang, Gao Zhu-Peng, Zheng Ying-Ying, Hu Chun-Mei, Lin Jing, Wu Xiao-Zheng, Zhang Xin, Zhou Yong-Sheng, Xiong Zhuang, Zhu Dao-Yong
School of Pharmacy and State Key Laboratory of Applied Organic Chemistry, Lanzhou University, Lanzhou, China.
School of Biotechnology and Health Sciences, Wuyi University, Jiangmen, China.
Front Chem. 2022 Jun 17;10:914944. doi: 10.3389/fchem.2022.914944. eCollection 2022.
In order to find potential inhibitors of tyrosinase, two series of pyrrole derivatives A (1-17) and B (1-8) were synthesized and screened for their inhibitory activities on tyrosinase. Most of the 2-cyanopyrrole derivatives exhibited effective inhibitory activities. In particular, A12 exhibited the strongest inhibitory activities, with the IC values of 0.97 μM, which is ∼30 times stronger than the reference inhibitor kojic acid (IC: 28.72 μM). The inhibitory mechanism analysis results revealed that A12 was a reversible and mixed-type inhibitor. Molecular docking experiments clarified the interaction between A12 with tyrosinase. Furthermore, A12 (100 μM) presented effective inhibitory effect on tyrosinase in B16 melanoma cells with inhibition of 33.48%, which was equivalent to that of Kojic acid (39.81%). Accordingly, compound A12 may serve as the lead structure for the further design of potent tyrosinase inhibitors. Molecular docking studies confirmed the interaction between the compound and tyrosinase.
为了寻找酪氨酸酶的潜在抑制剂,合成了两个系列的吡咯衍生物A(1 - 17)和B(1 - 8),并对它们对酪氨酸酶的抑制活性进行了筛选。大多数2 - 氰基吡咯衍生物表现出有效的抑制活性。特别是,A12表现出最强的抑制活性,IC值为0.97 μM,比参考抑制剂曲酸(IC:28.72 μM)强约30倍。抑制机制分析结果表明,A12是一种可逆的混合型抑制剂。分子对接实验阐明了A12与酪氨酸酶之间的相互作用。此外,A12(100 μM)对B16黑色素瘤细胞中的酪氨酸酶呈现出有效的抑制作用,抑制率为33.48%,与曲酸(39.81%)相当。因此,化合物A12可作为进一步设计强效酪氨酸酶抑制剂的先导结构。分子对接研究证实了该化合物与酪氨酸酶之间的相互作用。